Citigroup »

Immunovant shares owned by Citigroup

Quarter-by-quarter ownership of Immunovant (IMVT) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Immunovant

Tip: Access up to 7 years of quarterly data

All positions including Immunovant held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunovant by Citigroup

Quarter filed Position value Share count Share price at filing
2024-06-30 $835k 32k 26.42
2024-03-31 $8.1M 250k 32.30
2023-12-31 $5.2M 124k 42.11
2023-09-30 $4.9M 126k 38.43
2023-03-31 $5.6M 363k 15.51
2022-12-31 $1.8M 103k 17.75
2022-09-30 $17k 3.0k 5.75
2021-12-31 $1.3M 155k 8.52
2021-03-31 $3.9M 243k 16.04
2020-12-31 $834k 18k 46.17
2020-09-30 $77k 2.2k 35.08
2020-06-30 $318k 13k 24.31
2020-03-31 $25k 1.6k 15.36